Teva says vaccine makers have not taken its offer to help produce jabs | Financial Times
Teva faces class-action lawsuit over US antitrust probe into price-fixing | The Times of Israel
TEVA Stock Price and Chart — NYSE:TEVA — TradingView
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
US Supreme Court sides with Teva in drug dispute
Teva Pharmaceutical Industries Ltd | Reuters
Teva Pharmaceuticals gets a coronavirus boost, but it won't last long - Business - Haaretz.com
Teva Pharm Q3 profit misses estimates, sees recovery into Q4 By Reuters
GSK's $235 million verdict revived against Teva, again | Reuters.com
What's 'down' with Teva? - The Jerusalem Post
Teva Pharmaceutical Industries Ltd | Reuters
Reuters report cited by Mylan executive chairman in letter to Teva CEO - Reuters News Agency
/cloudfront-us-east-2.images.arcpublishing.com/reuters/5OMAQFWFHNJDZCDZKKO5DWLBG4.jpg "Teva Israel enters medical cannabis market with new partnership | Reuters")
Teva Israel enters medical cannabis market with new partnership | Reuters
Outrage as Teva charges $18,275 for generic drug in US - The Jerusalem Post
/cloudfront-us-east-2.images.arcpublishing.com/reuters/ANJL4AXVTBOMDKS2X4DIJZXZAY.jpg "Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters")
Teva loses bid to cancel Corcept drug patent at Federal Circuit | Reuters
Shlomo Yanai, Teva's president and chief executive, addresses the media during a news conference in Tel Aviv July 27, 2010. Teva Pharmaceutical Industries, the world's largest generic drugmaker, reported higher quarterly net
Teva settles shareholder lawsuit over generic drug pricing for $420 million | Reuters.com
A Drug Company Wagers the U.S. Won't Dare Charge It With Crimes - The New York Times
Incoming Teva CEO Jeremy Levin attends a news conference in Tel Aviv January 2, 2012. Teva Pharmaceutical Industries, the world's largest generics drugmaker, said on Monday that Shlomo Yanai would step down
Teva buys Anda for $500 million - ISRAEL21c
